aim
hospit
networkbas
retrospect
observ
studi
aim
describ
preval
season
paediatr
adult
viral
respiratori
pathogen
rate
coinfect
follow
introduct
rapid
multiplex
molecular
diagnost
assay
method
nasopharyng
sampl
test
patient
present
monash
health
melbourn
australia
august
juli
mean
multiplex
tandem
polymeras
chain
reaction
use
respiratori
pathogen
kit
ausdiagnost
includ
analysi
result
patient
sampl
analys
duplic
sampl
exclud
posit
result
twice
like
paediatr
compar
adult
coinfect
frequent
paediatr
posit
compar
adult
adenoviru
high
preval
coinfect
paediatr
test
frequenc
increas
paediatr
group
adult
year
observ
conclus
studi
demonstr
signific
differ
posit
detect
rate
pathogen
coinfect
popul
group
adenoviru
surprisingli
high
preval
coinfect
especi
paediatr
patient
studi
period
rapid
uptak
test
observ
especi
adult
rais
concern
ensur
test
remain
ration
abl
provid
costeffect
manner
futur
respiratori
viru
detect
ns
ching
et
al
respiratori
tract
infect
common
caus
hospit
admiss
young
children
viral
pathogen
account
communityacquir
pneumonia
children
rapid
molecular
diagnost
allow
easi
detect
viral
pathogen
includ
multipl
pathogen
paper
add
high
preval
adenoviru
coinfect
paediatr
popul
although
low
overal
also
high
preval
adenoviru
coinfect
amongst
adult
uptak
rate
rapid
molecular
test
year
sinc
introduct
small
paediatr
compar
adult
cohort
respiratori
tract
infect
rti
common
caus
hospitalis
young
children
viral
pathogen
account
greater
communityacquir
pneumonia
cap
children
viral
aetiolog
attribut
adult
admit
cap
condit
overal
mortal
signific
given
sever
cap
case
adult
attribut
influenza
alon
increas
avail
rapid
molecular
diagnost
multipl
respiratori
virus
allow
easier
identif
viral
pathogen
use
amplif
diagnost
assay
enabl
detect
even
low
level
viru
provid
high
sensit
result
rapid
uptak
test
recent
year
larg
replac
less
sensit
andor
labourintens
cultur
antigen
detect
methodolog
given
emerg
improv
therapi
viral
respiratori
diseas
identif
rel
contribut
virus
rti
present
may
aid
clinic
manag
inform
health
system
preval
pathogen
aim
describ
frequenc
viral
respiratori
pathogen
detect
paediatr
adult
popul
health
network
follow
implement
respiratori
multiplex
polymeras
chain
reaction
pcr
assay
analysi
conduct
describ
preval
coinfect
improv
sensit
increas
use
multiplex
analysi
led
increas
detect
one
potenti
pathogen
singl
sampl
method
studi
conduct
monash
health
melbourn
australia
inpati
bed
hospit
region
network
incorpor
monash
children
hospit
three
emerg
depart
encompass
km
catchment
region
southeast
melbourn
monash
health
servic
greater
commun
million
resid
cover
approxim
victoria
popul
secondari
tertiari
hospit
children
adult
within
network
patient
test
use
respiratori
multiplex
pcr
includ
paediatr
defin
younger
year
age
adult
defin
year
respiratori
multiplex
pcr
result
retrospect
extract
monash
patholog
laboratori
inform
system
span
period
august
juli
nasopharyng
sampl
test
respiratori
pathogen
multiplex
panel
includ
studi
nasopharyng
sampl
collect
aspir
swab
use
minitip
flock
swab
contain
univers
transport
medium
interpath
melbourn
australia
total
nucleic
acid
extract
perform
use
nuclisen
easymag
platform
accord
instruct
manufactur
biomerieux
marci
letoil
franc
elut
sampl
elut
buffer
test
use
multiplex
tandem
pcr
mtpcr
liquidhandl
robot
system
previous
describ
ausdiagnost
melbourn
australia
use
respiratori
pathogen
kit
detect
influenza
includ
influenza
influenza
b
respiratori
syncyti
viru
rsv
picornaviru
human
rhinovirus
human
enterovirus
parainfluenza
parainfluenza
parainfluenza
adenoviru
human
type
human
metapneumoviru
bacteria
bordetella
pertussi
definit
purpos
posit
sampl
design
begin
infect
period
beyond
period
repeat
test
consid
new
sampl
regardless
result
singl
infect
defin
detect
one
viru
sampl
coinfect
defin
detect
two
pathogen
singl
sampl
descript
analysi
perform
use
microsoft
excel
microsoft
redmond
ca
usa
twosampl
test
proport
perform
use
stata
statacorp
colleg
station
tx
usa
number
percentag
pathogen
detect
coinfect
determin
detect
rate
pathogen
rate
coinfect
determin
comparison
paediatr
adult
data
pathogen
made
includ
pathogen
commonli
isol
group
state
protocol
qualiti
assur
project
approv
monash
health
ethic
committe
studi
retrospect
extract
nonidentifi
data
monash
health
patholog
system
inform
consent
obtain
individu
patient
studi
conduct
monash
health
human
research
ethic
committe
approv
mention
total
patient
sampl
analys
follow
remov
duplic
sampl
posit
result
detect
paediatr
sampl
adult
sampl
fig
common
pathogen
detect
picornaviru
next
common
pathogen
rsv
paediatr
influenza
adult
tabl
season
pathogen
display
group
figur
paediatr
show
consist
high
peak
rsv
around
june
influenza
preval
adult
seen
peak
around
septemb
season
note
picornaviru
amongst
either
paediatr
adult
detect
multipl
respiratori
pathogen
common
shown
figur
paediatr
adult
sampl
identifi
two
pathogen
common
combin
group
rsv
picornaviru
amongst
adult
close
follow
influenza
picornaviru
adult
sampl
three
pathogen
yield
nine
differ
pathogen
combin
major
adenoviru
detect
paediatr
seen
set
pathogen
adult
also
consider
proport
detect
coinfect
increas
number
sampl
perform
observ
period
final
year
august
paediatr
sampl
adult
sampl
analys
compar
paediatr
adult
sampl
first
year
tabl
report
result
hospit
networkbas
studi
compar
detect
viral
pathogen
children
adult
present
background
popul
use
respiratori
multiplex
pcr
assay
paediatr
sampl
twice
like
yield
posit
result
vs
rapid
uptak
frequenc
test
observ
across
studi
period
especi
adult
popul
almost
increas
test
perform
per
annum
compar
across
year
children
increas
observ
indic
test
includ
abil
chang
patient
manag
either
directli
infect
control
reason
assist
communic
diseas
epidemiolog
respiratori
test
uncomfort
procedur
incur
expens
rapid
uptak
test
period
highlight
need
test
behaviour
remain
ration
costeffect
set
prolong
viral
shed
long
clinic
resolut
diseas
posit
result
may
even
disadvantag
patient
healthcar
provid
due
unnecessari
period
respiratori
viru
isol
infect
inpati
abil
perform
test
obtain
posit
result
alon
insuffici
reason
conduct
respiratori
test
proport
paediatr
pcrposit
respiratori
sampl
compar
studi
report
rate
adult
popul
less
avail
evid
comparison
exclus
specif
subpopul
inclus
paediatr
patient
avail
data
proport
posit
sampl
appear
compar
annual
season
may
august
inclus
detect
rate
paediatr
rsv
infect
similar
studi
report
rate
detect
rate
adult
influenza
infect
annual
season
consist
studi
rsv
higher
rate
amongst
paediatr
popul
compar
adult
wherea
influenza
like
detect
amongst
adult
popul
previous
recognis
observ
commonli
identifi
pathogen
group
picornaviru
total
posit
result
paediatr
adult
make
easili
commonli
identifi
pathogen
popul
group
across
numer
studi
picornaviru
remain
common
respiratori
pathogen
identifi
presenc
also
contribut
signific
proport
coinfect
overal
nearli
coinfect
contain
threepathogen
combin
rais
question
possibl
role
picornaviru
respiratori
ill
present
children
adult
may
primari
pathogen
cofactor
viral
bacteri
infect
trigger
noninfect
respiratori
present
asthma
import
recognis
howev
high
detect
picornaviru
amongst
healthi
individu
well
describ
howev
recent
concomit
blood
respiratori
pcr
detect
rhinoviru
children
sign
lower
rti
suggest
may
play
role
one
six
children
rti
test
posit
rhinoviru
incid
coinfect
paediatr
posit
result
margin
higher
describ
studi
previou
studi
also
demonstr
lower
coinfect
rate
adult
high
proport
adenoviru
infect
present
coinfect
also
recent
describ
amongst
children
cap
although
describ
scale
previous
adenoviru
also
present
signific
proport
adult
coinfect
recent
largescal
prospect
studi
southern
china
describ
respiratori
viral
infect
children
adult
usual
pcr
techniqu
differ
select
virus
test
influenza
b
c
rsv
adenoviru
human
metapneumoviru
parainfluenza
viru
human
coronaviru
human
bocaviru
rate
overal
posit
result
lower
identifi
rate
coinfect
significantli
higher
vs
sampl
vs
posit
sampl
may
explain
differ
virus
test
popul
factor
indic
test
multiplex
pcr
test
common
respiratori
pathogen
therefor
introduc
sever
limit
unabl
determin
individu
contribut
enteroviru
rhinoviru
report
picornaviru
base
target
mani
respiratori
viral
pathogen
test
eg
coronaviru
bocaviru
influenza
c
inclus
may
help
close
diagnost
gap
paediatr
adult
test
neg
studi
demonstr
rel
reproduc
season
respiratori
pathogen
amongst
requir
present
admiss
hospit
absenc
correl
clinic
data
possibl
conclud
presenc
respiratori
pathogen
caus
clinic
diseas
high
sensit
molecular
diagnost
assay
abil
detect
low
level
viru
led
high
yield
test
children
present
rti
undergo
respiratori
viral
pathogen
detect
howev
interpret
posit
result
complex
may
repres
caus
pathogen
present
ill
prolong
shed
past
infect
simpli
asymptomat
infect
sinc
introduct
test
asymptomat
carriag
respiratori
pathogen
confirm
test
describ
high
preval
picornaviru
coinfect
describ
previous
howev
far
know
first
time
high
preval
adenoviru
document
howev
rais
question
regard
clinic
signific
burden
diseas
associ
present
singlepathogen
detect
versu
coinfect
advent
increas
respiratori
viral
therapeut
vaccin
preclin
clinic
develop
abil
understand
potenti
role
mani
virus
like
deepen
clinic
trial
postlicensur
data
abil
sensit
molecular
assay
improv
abil
provid
potenti
explan
symptom
howev
old
challeng
remain
high
sensit
test
rais
new
issu
old
challeng
whether
posit
test
regularli
chang
clinic
manag
patient
test
remain
debat
abil
newer
assay
detect
nonviabl
viral
rna
dna
add
complex
interpret
posit
result
may
help
explain
coinfect
nevertheless
continu
improv
abil
understand
infecti
diseas
epidemiolog
also
complex
interact
potenti
respiratori
pathogen
adult
child
host
